Announcements Trials
Browse Landscape

Phase

Phase 2 143Phase 1 99Phase 1/2 66Phase 3 43Phase NA 11Phase 2/3 9Phase 4 4Phase EARLY_PHASE1 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1

Conditions

Myelodysplastic Syndromes 2Leukemia, Neutrophilic, Chronic 1Leukemia, Myelomonocytic, Chronic 1Leukemia, Myeloid, Acute 1Ependymoma 1Brain Neoplasms 1

Interventions

Cytarabine 3Cyclophosphamide 3pembrolizumab 2fludarabine 2Idarubicin 2Etoposide 2venetoclax 1ioversol 1interferon gamma-1b 1fludarabine phosphate 1fluarix 1dubermatinib 1daratumumab 1asparaginase erwinia chrysanthemi recombinant 1alovudine 1Whole-Body Irradiation 1Transplantation 1Sodium Bicarbonate 1Sirolimus 1Photography 1Pemetrexed 1Mycophenolic Acid 1Mesenchymal Stem Cell Transplantation 1Magnetic Resonance Spectroscopy 1Injections 1Influenza Vaccines 1Immunotherapy, Adoptive 1Immune Checkpoint Inhibitors 1Hyperbaric Oxygenation 1Gemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase EARLY_PHASE1 × Leukemia, Myeloid, Acute × Azacitidine × Clear all
NCT04518345 2023-02-06

TP-0903 for the Treatment of FLT3 Mutated Acute Myeloid Leukemia

Ohio State University Comprehensive Cancer Center

Phase EARLY_PHASE1 Completed
3 enrolled
Other hematologic neoplasm

Leukemia, Myeloid, Acute

Data powered by HemOnc (CC BY 4.0) Colophon âš¡